Managing inflammatory bowel disease

Bernard W. Chin*, Michael C. Grimm, Susan J. Connor, Rupert W. Leong

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

• IBD can be difficult to diagnose. The key is to suspect IBD when patients present with chronic gastrointestinal tract (GIT) symptoms that are not easily explained. • The aim of management of IBD is to induce and maintain remission and prevent the long term consequences of GIT inflammation. This is usually achieved medically, but surgery can sometimes be the best option. The avoidance of long term corticosteroid treatment is important. • The management of patients with severe and refractory IBD is changing with the advent of powerful new drugs such as the anti-tumour necrosis factor agents. Multinational, multicentre clinical trials are enrolling suitable patients in many Australian teaching hospitals to study these agents. • IBD is chronic and can be complex. It is best managed in a multidisciplinary way by a gastroenterologist, GP, surgeon and dietitian.

Original languageEnglish
Pages (from-to)14-23
Number of pages10
JournalMedicine Today
Volume7
Issue number11
Publication statusPublished - Nov 2006
Externally publishedYes

Fingerprint Dive into the research topics of 'Managing inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this